Electronic Messaging Intervention Cuts Cardiovascular Risk in T2DM

This article originally appeared here.
Share this content:
Electronic Messaging Intervention Cuts Cardiovascular Risk in T2DM
Electronic Messaging Intervention Cuts Cardiovascular Risk in T2DM

WEDNESDAY, July 19, 2017 (HealthDay News) -- For patients with type 2 diabetes mellitus, a electronic messaging intervention is effective for reducing cardiovascular risk, according to a study published online July 12 in the Journal of Clinical Nursing.

Ronghua Fang, R.N., and Xuexue Deng, R.N., from the West China Hospital Sichuan University in Chengdu, conducted a convenience sample study with randomized group assignment to examine the effectiveness of an electronic messaging support service for management of cardiovascular risk factors in patients with type 2 diabetes. Participants completed surveys and underwent physical and laboratory evaluations, and were randomized to either receipt of electronic messages or a phone call. Intervention patients received appointment reminders and health information via electronic message. Intervention and control patients were followed-up every three months by telephone.

The researchers found that between-group differences were statistically significant in glycated hemoglobin, postprandial plasma glucose, postprandial insulin, total cholesterol, and low-density lipoprotein cholesterol. In intervention patients, there were significant decreases in levels of glycated hemoglobin, fasting plasma glucose, postprandial plasma glucose, fasting insulin, postprandial insulin, total cholesterol, and low-density lipoprotein cholesterol. Patients only followed by telephone had a significant decrease in systolic blood pressure.

"Regular smartphone communication had a favorable impact on cardiovascular risk factors in patients with type 2 diabetes mellitus," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

For patients with relapsed or refractory B-cell ALL who have received one or two prior treatments

Online Nursing Education Can Up Patient Use of VTE Prophylaxis

Online Nursing Education Can Up Patient Use of ...

Online training aims to make sure those hospitalized get treatment to prevent venous thromboembolism

On-Pump CABG Leads to Higher Rates of Five-Year Survival

On-Pump CABG Leads to Higher Rates of Five-Year ...

Study compared coronary-artery bypass grafting surgery, with/without cardiopulmonary bypass

is free, fast, and customized just for you!

Already a member?

Sign In Now »